Lijuan Liu

Fuzhou, 350025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Boosting single-particle luminescence of nanoprobes via in situ enrichment of lanthanide fluorides in dendritic silica for ultrasensitive cancer detection.

Boosting single-particle luminescence of nanoprobes via in situ enrichment of lanthanide fluorides in dendritic silica for ultrasensitive cancer detection.

Journal: Science bulletin

Published: January 25, 2026

Development and validation of GADA model for diagnosing hepatocellular carcinoma in Chinese hepatitis B patients.

Development and validation of GADA model for diagnosing hepatocellular carcinoma in Chinese hepatitis B patients.

Journal: Chinese medical journal

Published: December 25, 2025

Serum hepatitis B virus RNA as a predictive biomarker for HBeAg seroconversion during entecavir and tenofovir disoproxil fumarate therapy in chronic hepatitis B patients.

Serum hepatitis B virus RNA as a predictive biomarker for HBeAg seroconversion during entecavir and tenofovir disoproxil fumarate therapy in chronic hepatitis B patients.

Journal: Revista espanola de enfermedades digestivas

Published: June 27, 2025

Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers.

Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers.

Journal: Journal of hepatocellular carcinoma

Published: November 01, 2023

3'UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling.

3'UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling.

Journal: Frontiers in immunology

Published: April 20, 2022

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.

Journal: Frontiers in immunology

Published: September 14, 2021

Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study.

Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 23, 2021

The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China.

The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China.

Journal: Journal of clinical laboratory analysis

Published: April 15, 2021

N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.

N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.

Journal: International journal of cancer

Published: November 13, 2020

Serum N-glycan fingerprint nomogram predicts liver fibrosis: a multicenter study.

Serum N-glycan fingerprint nomogram predicts liver fibrosis: a multicenter study.

Journal: Clinical chemistry and laboratory medicine

Published: October 20, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026